Analyst Research Report Snapshot

Title:

VECTURA - INSPIRING CONFIDENCE

Price:

$10.00

Provider:

Edison Investment Research

Date:

04 Dec 2009

Pages:

12

Type:

AcrobatPDF

Companies referenced:

VEC.L

Available for Immediate Download
Summary:

Vectura offers an investment geared to the success of its inhaled therapy portfolio, principally its two branded and two generic products projects that are partnered with Novartis. These should reach key development milestones over the next 18 months. Vectura is well financed and establishing a US office, which could become the base for a future US sales force. The ending of a collaboration with Boehringer Ingelheim (BI) allows Vectura to consider developing a generic version of the blockbuster Spiriva. FOR MORE INFORMATION ON THE ATTACHED RESEARCH PLEASE CALL 020 3077 5700, EMAIL RESEARCH@EDISONINVESTMENTRESEARCH.CO.UK OR VISIT WWW.EDISONINVESTMENTRESEARCH.CO.UK

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.